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Clinical Infectious Diseases
SUPPLEMENT ARTICLE

The Diagnostic Utility of Induced Sputum Microscopy and
Culture in Childhood Pneumonia
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Background. Sputum microscopy and culture are commonly used for diagnosing the cause of pneumonia in adults but are
rarely performed in children due to difficulties in obtaining specimens. Induced sputum is occasionally used to investigate lower
respiratory infections in children but has not been widely used in pneumonia etiology studies.
Methods. We evaluated the diagnostic utility of induced sputum microscopy and culture in patients enrolled in the Pneumonia Etiology
Research for Child Health (PERCH) study, a large study of community-acquired pneumonia in children aged 1–59 months. Comparisons
were made between induced sputum samples from hospitalized children with radiographically confirmed pneumonia and children categorized as nonpneumonia (due to the absence of prespecified clinical and laboratory signs and absence of infiltrate on chest radiograph).
Results. One induced sputum sample was available for analysis from 3772 (89.1%) of 4232 suspected pneumonia cases enrolled
in PERCH. Of these, sputum from 2608 (69.1%) met the quality criterion of <10 squamous epithelial cells per low-power field, and
1162 (44.6%) had radiographic pneumonia. Induced sputum microscopy and culture results were not associated with radiographic
pneumonia, regardless of prior antibiotic use, stratification by specific bacteria, or interpretative criteria used.
Conclusions. The findings of this study do not support the culture of induced sputum specimens as a diagnostic tool for pneumonia in young children as part of routine clinical practice.
Keywords. pneumonia; induced sputum; culture; microscopy; children.

Microscopy and culture of sputum specimens are standard
techniques commonly used by diagnostic laboratories to evaluate pneumonia in adults. Despite difficulties interpreting results
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[1], carefully collected and processed sputum specimens have
been shown to be useful diagnostic tools in some contexts [2].
Nonetheless, ongoing controversy continues about the value
of routinely examining sputum [3–7]. Furthermore, sputum
microscopy and culture are not routinely performed in children, who are typically unable to expectorate, making it difficult
to obtain specimens [8].
Induced sputum is widely used to investigate lower respiratory infections in immunocompromised adults, especially for
diagnosing Pneumocystis jirovecii infection [9]. It has also
been used to diagnose pneumonia in children from settings
with a high prevalence of tuberculosis [10]. However, few

studies have collected induced sputum routinely from children with pneumonia. Recent studies of children hospitalized
with community-acquired pneumonia from Finland, Kenya,
and New Caledonia showed that collection of induced sputum was well tolerated, with a diagnostic yield from culture
ranging from 12% to 65% using different interpretative criteria [11–14].
We made a decision to include microscopy and culture of
induced sputum as part of the Pneumonia Etiology Research
for Child Health (PERCH) study, a large case-control study
involving 9 sites in 7 countries from sub-Saharan Africa and
south Asia [15, 16]. The expectation was that this approach may
help overcome the inherent difficulties with obtaining specimens from the lower respiratory tract in children with pneumonia and facilitate the diagnosis of pneumonia etiology. In an
accompanying article we show that low numbers of squamous
epithelial cells (SECs) was the best measure of induced sputum
quality in children with pneumonia from the PERCH study,
as evidenced by low quantities of oropharyngeal flora and
higher prevalence of putative pathogens. A large proportion
of induced sputum samples met this criterion for good quality, suggesting that most specimens originated from the lower
respiratory tract [17]. Here, we evaluate the diagnostic utility
of induced sputum microscopy and culture in the PERCH
study. A specific objective was to determine whether sputum
culture results should be included in the primary etiology analysis of the study. Other companion articles in this supplement
focus on the agreement of polymerase chain reaction results
between induced sputum and nasopharyngeal/oropharyngeal
specimens, safety of induced sputum collection, and utility of
induced sputum for diagnosing tuberculosis [18–20].
METHODS
Participants

Participants were children aged 1–59 months who were hospitalized with World Health Organization (WHO)–defined
severe or very severe pneumonia as part of the PERCH
case-control study, details of which have been described elsewhere [21, 22].
Chest Radiography

Chest radiographs (CXRs) from each child were interpreted by
a panel of radiologists and pediatricians trained in the standardized interpretation of pediatric CXRs [23]. CXRs were
classified as demonstrating consolidation, other infiltrate,
both consolidation and other infiltrate, or as being normal or
uninterpretable.
Specimen Collection

Induced sputum was obtained from cases at enrollment as
described in detail in an accompanying article [17].

Laboratory Methods

Gram stain smears were made from the most visually purulent
portion of each induced sputum specimen. The quality of sputum
was assessed microscopically as outlined elsewhere [17], and only
specimens with <10 SECs per (100×) low-power field (LPF) were
included in further analyses. Microorganisms seen in the smear
under (1000×) high power were described according to classic
Gram stain morphotypes, and relative numbers of each type were
recorded within the following categories: 1 (scanty), 2–9 (1+),
10–99 (2+), ≥100 (3+) per representative high-power field.
The most purulent portion of each specimen was inoculated
onto sheep or horse blood, chocolate, and MacConkey agars;
streaked out using a standard 4-quadrant streaking method;
and incubated at 35°C for 48 hours. Cultures were examined at
24 hours and 48 hours, and predominant organisms were identified and quantified according to the furthest quadrant with
visible colonies (first quadrant = scanty; second quadrant = 1+;
third quadrant = 2+; fourth quadrant = 3+).
In order to standardize reporting across sites, uniform standard operating procedures, on-site training, and internal and
external quality checks were established [24].
Study Definitions The following definitions were used in the
study.
Sputum Culture Positivity. Sputum culture results can be
interpreted in a variety of ways and no one consistent approach
is used by diagnostic laboratories. In general, it is recommended
that potential pathogens must be present as a predominant isolate, usually with a compatible Gram stain appearance [25, 26].
For the interpretative criteria used in this study, we reported
separately both organisms cultured in any amount and organisms cultured as the predominant isolate with compatible Gram
stain morphotype seen on microscopy.
CXR+ Cases and Nonpneumonia Cases. CXR+ pneumonia was
defined by the presence of consolidation and/or other infiltrate on
CXR [23]. Given that WHO-defined severe or very severe pneumonia has poor specificity for CXR+ pneumonia, a proportion of
the enrolled cases likely did not have true pneumonia. Using baseline clinical and laboratory characteristics and the absence of CXR
changes, a group of “control” children unlikely to have pneumonia (nonpneumonia) were identified. Children who met all of the
following 3 criteria were defined as “nonpneumonia”: presence of
a normal CXR, negative blood cultures, either normal respiratory
rate or nonhypoxic in the absence of crackles or normal respiratory rate and nonhypoxic in the presence of crackles. We compared
pneumonia to nonpneumonia cases for all analyses.
Prior Antimicrobial Therapy. Prior antimicrobial therapy
was defined as antibiotic activity in serum by bioassay or documentation of antibiotic administration before induced sputum
sample collection [27].
Microbiologically Confirmed Cases. Cases were defined as
having microbiologically confirmed pneumonia if they had a
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0 (0.0)

5 (2.1)

Klebsiella pneumoniae only

Mixed gram-negative
rods

2 (0.9)

0 (0.0)

2 (0.9)

Pseudomonas
aeruginosa

2 (0.9)

2 (0.9)
0 (0.0)

1 (0.5)

10 (5.1)

5 (2.5)

8 (4.1)

121 (61.4)

146 (74.1)

1 (0.5)

6 (3.0)

126 (64.0)

Any
Quantity

Mali
N = 126

Zambia
N = 194

South Africa
N = 198

Bangladesh
N = 142

0 (0.0)

1 (0.5)

1 (0.5)

2 (1.0)

3 (1.5)

68 (34.5)

105 (53.3)

0 (0.0)

3 (1.5)

79 (40.1)

1 (0.8)

6 (4.8)

0 (0.0)

7 (5.6)

19 (15.1)

30 (23.8)

56 (44.4)

3 (2.4)

17 (13.5)

17 (13.5)

1 (0.8)

3 (2.4)

0 (0.0)

5 (4.0)

11 (8.7)

19 (15.1)

36 (28.6)

3 (2.4)

4 (3.2)

10 (7.9)

0 (0.0)

2 (1.0)

0 (0.0)

20 (10.3)

24 (12.4)

57 (29.4)

62 (32.0)

0 (0.0)

21 (10.8)

36 (18.6)

0 (0.0)

1 (0.5)

0 (0.0)

6 (3.1)

8 (4.1)

29 (14.9)

22 (11.3)

0 (0.0)

1 (0.5)

18 (9.3)

1 (0.5)

1 (0.5)

6 (3.0)

20 (10.1)

35 (17.7)

30 (15.2)

53 (26.8)

2 (1.0)

32 (16.2)

47 (23.7)

0 (0.0)

0 (0.0)

4 (2.0)

4 (2.0)

6 (3.0)

8 (4.0)

10 (5.1)

1 (0.5)

11 (5.6)

26 (13.1)

1 (0.7)

14 (9.9)

19 (13.4)

2 (1.4)

5 (3.5)

6 (4.2)

58 (40.8)

1 (0.7)

7 (4.9)

59 (41.5)

1 (0.7)

1 (0.7)

8 (5.6)

2 (1.4)

2 (1.4)

5 (3.5)

49 (34.5)

1 (0.7)

3 (2.1)

49 (34.5)

0 (0.0)

0 (0.0)

2 (2.8)

1 (1.4)

1 (1.4)

22 (30.6)

12 (16.7)

0 (0.0)

9 (12.5)

23 (31.9)

Enterobacteriaceae includes Escherichia coli, Enterobacter species, Klebsiella species, Citrobacter species, and Serratia species, excluding mixed gram-negative rods. Klebsiella pneumoniae also reported separately.

Other nonfermentative gram-negative rods includes Acinetobacter species and Pseudomonas species. Pseudomonas aeruginosa also reported separately.

e

d

Other streptococci and enterococci includes Streptococci (other than S. pneumoniae) and Enterococci species.

c

Isolated as the predominant organisms with compatible Gram stain morphotype.

Number of cases at each site who had high-quality induced sputum and radiographic pneumonia.

b

a

Thailand
N = 72

0 (0.0)

0 (0.0)

1 (1.4)

0 (0.0)

0 (0.0)

16 (22.2)

7 (9.7)

0 (0.0)

7 (9.7)

19 (26.4)

Any
Any
Any
Any
Any
Predominant Quantity Predominant Quantity Predominant Quantity Predominant Quantity Predominant Quantity Predominant

Gambia
N = 197

High-quality induced sputum defined as <10 epithelial cells per low-power field. Radiographic pneumonia defined as any abnormal chest radiograph (consolidation and/or other infiltrates).

3 (1.3)

All

Other nonfermentative gram-negative rodse

11 (4.7)

All

4 (1.7)

70 (30.0)

Enterobacteriaceaed

33 (14.2)

Moraxella catarrhalis

97 (41.6)

Haemophilus influenzae 86 (36.9)

0 (0.0)

0 (0.0)

2 (0.9)

0 (0.0)

39 (16.7)

Other streptococci and
enterococcic

58 (24.9)

Any
Quantity Predominantb

Staphylococcus aureus

Streptococcus
pneumoniae

Bacteria

Kenya
Na = 233

Study Site (n, %)

5 (0.4)

27 (2.3)

42 (3.6)

55 (4.7)

103 (8.9)

363 (31.2)

473 (40.7)

7 (0.6)

94 (8.1)

366 (31.5)

Any
Quantity

4 (0.3)

8 (0.7)

16 (1.4)

19 (1.6)

34 (2.9)

215 (18.5)

262 (22.5)

5 (0.4)

29 (2.5)

240 (20.7)

Predominant

All Sites
N = 1162

Table 1. Prevalence of Bacteria Cultured in Any Quantity or as the Predominant Isolate With Compatible Gram Stain From High-Quality Induced Sputum from Children Aged 1–59 Months With World Health Organization–
Defined Severe or Very Severe Radiographic Pneumonia, by Study Site

Table 2. Prevalence of Bacteria Cultured in Any Quantity From High-Quality Induced Sputum Among Radiographic Pneumonia Cases and Nonpneumonia
Cases, by Antibiotic Exposure Status
Regardless of Antibiotic Exposurea

No Antibiotic Exposure

P Valued

CXR+
(N = 219)
n (%)

Nonpneumonia
(N = 124) n (%)

149 (37.4)

.03

141 (64.4)

76 (61.3)

94 (8.1)

27 (6.8)

.45

13 (5.9)

7 (0.6)

3 (0.8)

.72

2 (0.9)

Haemophilus influenzae

473 (40.7)

168 (42.2)

.60

148 (67.6)

84 (67.7)

Moraxella catarrhalis

363 (31.2)

156 (39.2)

.005

111 (50.7)

55 (44.4)

103 (8.9)

33 (8.3)

.76

12 (5.5)

55 (4.7)

15 (3.8)

.49

4 (1.8)

42 (3.6)

8 (2.0)

.14

27 (2.3)

11 (2.8)

5 (0.4)

3 (0.8)

CXR+b (N = 1162)
n (%)

Nonpneumoniac
(N = 398) n (%)

366 (31.5)

Staphylococcus aureus
Other streptococci and
enterococcie

Bacteria
Streptococcus
pneumoniae

Antibiotic Exposure
CXR+
(N = 908)
n (%)

Nonpneumonia
(N = 266) n (%)

.64

210 (23.1)

68 (25.6)

12 (9.7)

.20

80 (8.8)

15 (5.6)

.10

2 (1.6)

.62

4 (0.4)

1 (0.4)

>.99

>.99

302 (33.3)

77 (28.9)

.21

.26

238 (26.2)

96 (36.1)

.002

5 (4.0)

.62

89 (9.8)

27 (10.2)

.91

3 (2.4)

.71

50 (5.5)

12 (4.5)

.64

12 (5.5)

1 (0.8)

.04

28 (3.1)

7 (2.6)

.84

.58

1 (0.5)

2 (1.6)

.30

26 (2.9)

9 (3.4)

.68

.43

0 (0.0)

0 (0.0)

N/A

5 (0.6)

3 (1.1)

.39

P Value

P Value
.41

Enterobacteriaceaef
All
Klebsiella pneumoniae
Mixed gram-negative
rods

Other nonfermentative gram-negative rodsg
All
Pseudomonas aeruginosa

High-quality induced sputum defined as <10 epithelial cells per low-power field.
Abbreviation: CXR, chest radiograph.
a

Prior use of antibiotics defined as bioassay positive, antibiotic administration at the referral facility, antibiotic administration prior to induced sputum specimen collection at the study facility.

b

Radiographic pneumonia (CXR+) defined as any abnormal CXR (consolidation and/or other infiltrates).

c

Nonpneumonia case defined as a case with a normal CXR, blood culture pathogen negative, and normal respiratory rate or nonhypoxic in the absence of crackles, or normal respiratory
rate and nonhypoxic in the presence of crackles.
d

P value from χ2 or Fisher exact test.

e

Other streptococci and enterococci includes Streptococci (other than S. pneumoniae) and Enterococci species.

f

Enterobacteriaceae includes Escherichia coli, Enterobacter species, Klebsiella species, Citrobacter species, and Serratia species, excluding mixed gram-negative rods. Klebsiella pneumoniae also reported separately.

g

Other nonfermentative gram-negative rods include Pseudomonas aeruginosa, Acinetobacter species, Pseudomonas species. Pseudomonas aeruginosa also reported separately.

bacterium that was not regarded as a contaminant isolated from
blood, lung aspirate, or pleural fluid [27].
Statistical Analyses

We hypothesized that pneumonia pathogens are more likely to
be detected in sputum samples from children with radiographic
pneumonia compared to sputum samples from children in the
nonpneumonia group. Also, we hypothesized that pathogens
that cause pneumonia are likely to be present in high enough
quantities that they should be detected by both culture and
microscopy, and thus pediatric induced sputum cultures should
be interpreted in conjunction with Gram stain findings.
To assess whether pathogen detection was associated with
CXR+ pneumonia among hospitalized infants and young children, we calculated the prevalence of specific bacteria cultured
from high-quality induced sputum specimens from CXR+ cases
and nonpneumonia cases, stratified by site and prior antimicrobial therapy. Comparisons were made using the χ2 test. Odds
ratios were calculated for associations of pneumonia status with
organism presence using different interpretive criteria in order to
examine the effect of Gram stain results on observed associations.

Ethical Considerations

The institutional review board or ethical review committee at
each study site institution and at the Johns Hopkins Bloomberg
School of Public Health approved the PERCH study protocol.
Parents or guardians of participants provided written informed
consent.
RESULTS

Induced sputum culture results were available for analysis from
3772 (89.1%) of 4232 children enrolled in PERCH. Sputum
from 2608 (69.1%) met the quality criterion of <10 SECs per
LPF; of these, 1162 (44.6%) had radiographic pneumonia, 398
(15.3%) were nonpneumonia cases, and 1048 (40.2%) did not
meet either definition.
Of the 1162 CXR+ cases with high-quality induced sputum, 866 (74.5%) had severe pneumonia and 296 (25.5%) had
very severe pneumonia. A total of 197 (17.0%) were from the
Gambia, 126 (10.8%) from Mali, 233 (20.1%) from Kenya,
194 (16.7%) from Zambia, 198 (17.0%) from South Africa,
142 (12.2%) from Bangladesh, and 72 (6.2%) from Thailand.
The median age of these children was 8 months (interquartile
Induced Sputum Culture Evaluation • CID 2017:64 (Suppl 3) • S283

Table 3. Prevalence of Bacteria Cultured as the Predominant Organism With Compatible Gram Stain From High-Quality Induced Sputum Among
Radiographic Pneumonia Cases and Nonpneumonia Cases, by Antibiotic Exposure Status
Regardless of Antibiotic Exposurea
b

No Antibiotic Exposure
CXR+
(N = 219)
n (%)

Nonpneumonia
(N = 124) n (%)

90 (41.1)

55 (44.4)

>.99

3 (1.4)

>.99

2 (0.9)

CXR+
(N = 1162)
n (%)

Nonpneumoniac
(N = 398) n (%)

240 (20.7)

94 (23.6)

Staphylococcus aureus

29 (2.5)

9 (2.3)

Other streptococci and
enterococcie

5 (0.4)

2 (0.5)

Haemophilus influenzae

262 (22.5)

92 (23.1)

.84

104 (47.5)

60 (48.4)

Moraxella catarrhalis

215 (18.5)

93 (23.4)

.04

62 (28.3)

29 (23.4)

All

34 (2.9)

11 (2.8)

>.99

1 (0.5)

1 (0.8)

Klebsiella pneumoniae

19 (1.6)

6 (1.5)

>.99

1 (0.5)

0 (0.0)

16 (1.4)

2 (0.5)

.27

2 (0.9)

0 (0.0)

Bacteria
Streptococcus
pneumoniae

P Valued
.23

Antibiotic Exposure
CXR+
(N = 908)
n (%)

Nonpneumonia
(N = 266) n (%)

.57

139 (15.3)

37 (13.9)

4 (3.2)

.26

26 (2.9)

5 (1.9)

.52

1 (0.8)

>.99

3 (0.3)

1 (0.4)

>.99

.91

141 (15.5)

27 (10.2)

.03

.37

147 (16.2)

61 (22.9)

.01

>.99

32 (3.5)

10 (3.8)

.85

>.99

17 (1.9)

6 (2.3)

.62

.54

12 (1.3)

2 (0.8)

.75

P Value

P Value
.63

Enterobacteriaceaef

Mixed gram-negative
rods

Other nonfermentative gram-negative rodsg
All

8 (0.7)

7 (1.8)

.07

0 (0.0)

2 (1.6)

.13

8 (0.9)

5 (1.9)

.19

Pseudomonas
aeruginosa

4 (0.3)

3 (0.8)

.38

0 (0.0)

0 (0.0)

N/A

4 (0.4)

3 (1.1)

.20

High-quality induced sputum defined as <10 epithelial cells per low-power field.
Abbreviation: CXR, chest radiograph.
a

Prior use of antibiotics defined as bioassay positive, antibiotic administration at the referral facility, antibiotic administration prior to induced sputum specimen collection at the study facility.

b

Radiographic pneumonia (CXR+) defined as any abnormal CXR (consolidation and/or other infiltrates).

c

Nonpneumonia case defined as a case with a normal CXR, blood culture pathogen negative, and normal respiratory rate or nonhypoxic in the absence of crackles, or normal respiratory
rate and nonhypoxic in the presence of crackles.
d

P value from χ2 or Fisher exact test.

e

Other streptococci and enterococci includes Streptococci (other than S. pneumoniae) and Enterococci species.

f

Enterobacteriaceae includes Escherichia coli, Enterobacter species, Klebsiella species, Citrobacter species, and Serratia species, excluding mixed gram-negative rods. Klebsiella pneumoniae also reported separately.

g

Other nonfermentative gram-negative rods include Pseudomonas aeruginosa, Acinetobacter species, Pseudomonas species. Pseudomonas aeruginosa also reported separately.

range, 4–17), 493 (42.4%) were female, and 90 (7.8%) had
human immunodeficiency virus infection. Among this group,
908 (80.6%) had prior antimicrobial therapy before collection
of induced sputum, although the frequency varied by site
as follows: 43 (21.8%) at the Gambia, 112 (88.9%) at Mali,
213 (91.4%) at Kenya, 190 (97.9%) at Zambia, 178 (89.9%)
at South Africa, 104 (73.2%) at Bangladesh, and 68 (94.4%)
at Thailand.
Of the 398 nonpneumonia cases, 67 (16.8%) were from the
Gambia, 50 (12.6%) from Mali, 157 (39.5%) from Kenya, 48
(12.1%) from Zambia, 22 (5.5%) from South Africa, 28 (7.0%)
from Bangladesh, and 26 (6.5%) from Thailand. Relative to
the CXR+ cases, the nonpneumonia cases were slightly older
(median age 10 months; interquartile range, 3–20), less likely
to be female (34.4%), and less likely to have human immunodeficiency virus (1.0%) infection or to have evidence of prior
antimicrobial use (68.2%).
Table 1 shows the prevalence of bacteria cultured from
induced sputum samples with <10 SECs per LPF from CXR+
cases, by study site, using the 2 culture interpretative criteria
(ie, organisms cultured in any amount and organisms cultured
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as the predominant isolate with compatible Gram stain morphotype). Tables 2 and 3 show the prevalence of organisms
cultured from both CXR+ and nonpneumonia cases using
the 2 culture interpretative criteria, by antibiotic exposure status. Haemophilus influenzae, Streptococcus pneumoniae, and
Moraxella catarrhalis were the predominant organisms isolated
when measured as organism detected in any amount (Table 2)
or as the predominant organism (Table 3); their prevalence was
similar in CXR+ and nonpneumonia cases. Klebsiella pneumoniae was more commonly isolated from cases from South
Africa and Zambia, although this regional predominance was
less evident when the more rigorous interpretative criterion
(predominant organisms with compatible Gram stain morphotype) was used (Table 1). There was no predominant organism
in 323 (27.8%) high-quality induced sputum specimens from
cases with radiographic pneumonia.
Table 4 shows the organisms cultured from high-quality
induced sputum samples from the cases with microbiologically confirmed pneumonia. The same organism was isolated
from a normally sterile site and induced sputum in a minority of these cases overall; the exception being M. catarrhalis

N/A
0

DISCUSSION

High quality defined as <10 epithelial cells per low-power field.

Microbiologically confirmed pneumonia defined as a bacterium detected by blood culture or polymerase chain reaction/culture in lung aspirates or pleural fluid.

0
1
Klebsiella
pneumoniae

0 (0.0)

0 (0.0)

1

1

0

0

0

0

0

0
0
0
5
Moraxella
catarrhalis

4 (80.0)

4 (80.0)

2

N/A

2

1

0

0

0

1
1
0
12
Haemophilus
influenzae

8 (66.7)

4 (33.3)

N/A

3

5

0

0

0

1

0
0
0
11
Staphylococcus
aureus

4 (36.4)

1 (9.1)

1

3

2

0

0

N/A

0

0
0
1
35
Streptococcus
pneumoniae

17 (48.6)

9 (25.7)

15

14

N/A

1

2

2

0

Klebsiella
Species
Streptococcus
Group A
Enterobacter
cloacae
Escherichia
coli
Staphylococcus
aureus
Pseudomonas
aeruginosa
N

Isolated
in Any
Quantity
(n, %)

Isolated as the
Predominant
Organism With
Compatible
Gram Stain
(n, %)

Haemophilus
influenzae

Moraxella
catarrhalis

Streptococcus
pneumoniae

Mixed
GramNegative
Rods

Other Bacteria Cultured from Induced Sputum in Any Quantity
Same Bacteria Isolated
from Induced Sputum
Bacteria Isolated
from Normally
Sterile Site

Bacteria Cultured From High-Quality Induced Sputum Samples From Children Aged 1–59 Months With Microbiologically Confirmed Pneumonia
Table 4.

for which 4 of 5 cases with positive cultures from a normally
sterile site also had this organism isolated from induced
sputum.
Table 5 shows the odds ratios associated with CXR+ case
status for detection of the major potential pathogen groupings in induced sputum with varying culture interpretative
criteria. For all organisms there was either no association or a
negative association between CXR+ pneumonia and the isolation of a pathogenic organism from induced sputum. For
all organisms there was either no association or a negative
association with the isolation of a pathogenic organism from
induced sputum and CXR+ pneumonia (Table 5). This pattern was consistent across all levels of interpretative criteria
(Supplementary Table 1).
None of the reported findings changed when another, more
rigorous, sputum culture interpretative criterion was used,
namely, requiring that organisms be isolated in quantities of
2+ or 3+, with or without compatible Gram stain appearance.

The key finding of this study is that culture of a potential pathogen from induced sputum was not clearly associated with radiographic pneumonia in young children compared to a group of
hospitalized children unlikely to have pneumonia, even when a
sputum quality standard was applied.
When sputum culture is used in pneumonia etiology studies,
predefined criteria have been traditionally used to determine
results thought to be associated with pneumonia causation [11,
13, 28, 29]. Only high-quality specimens that contain low numbers of SECs are typically accepted for analysis, and potential
pathogens are required to be present as a predominant isolate,
usually with a compatible Gram stain appearance [25, 26].
These criteria are derived from expert opinion, and their usefulness has been regularly debated [3–7, 30]. Had we applied
this traditional approach to using sputum culture results in the
PERCH study, the prevalence data shown in the second column
of Table 3 would have been simply incorporated into the main
etiologic analysis without further scrutiny. However, there was
sufficient concern about the reliability of this approach with
pediatric induced sputum specimens that we sought additional
evidence of diagnostic utility.
Without a suitable comparator gold standard, it is difficult
to determine the diagnostic accuracy of sputum culture for
identifying pneumonia etiology. In this study, we compared
cases of CXR+ pneumonia with a group of patients who
(despite fulfilling the WHO case definition for severe or very
severe pneumonia) were unlikely to have pneumonia. This
approach is based on the assumption that true bacterial pneumonia pathogens will be overrepresented in induced sputa
from children with CXR+ pneumonia compared to children
unlikely to have pneumonia. We found no clear association
between positive sputum culture results and pneumonia
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Table 5. Odds Ratio Associated With Radiographic Pneumonia Case (N = 1162) Versus Nonpneumonia Case (Reference) (N = 398) as a Predictor of
Organism Presence Among Cases With High-Quality Induced Sputum Samples

Haemophilus influenzae
Sputum Culture
Interpretative Criteria

Streptococcus
pneumoniae

Staphylococcus aureus

Moraxella catarrhalis

Other Gram-Negative
Rodsa

OR
(95% CI)

P
Value

OR
(95% CI)

P
Value

OR
(95% CI)

P
Value

OR
(95% CI)

P
Value

OR
(95% CI)

P
Value

Present in any
quantity

0.94 (0.75,1.18)

.60

0.77b (0.61,0.97)

.03

1.21 (0.78,1.89)

.40

0.69b (0.54,0.87)

<.01

1.61 (0.91,2.85)

.10

Present in any quantity with compatible
Gram stain

0.98 (0.76,1.26)

.87

0.86 (0.67,1.1)

.22

0.97 (0.51,1.85)

.94

0.72b (0.55,0.93)

<.01

1.38 (0.66,2.89)

.39

Present in any
quantity without
compatible Gram
stain

0.91 (0.65,1.27)

.57

0.62b (0.4,0.98)

.04

1.41 (0.78,2.57)

.25

0.77 (0.52,1.13)

.18

1.91 (0.79,4.59)

.15

Predominant
organism

0.91 (0.72,1.16)

.46

0.73b (0.57,0.94)

<.01

1.19 (0.72,1.96)

.50

0.67b (0.52,0.86)

<.01

1.42 (0.73,2.77)

.31

Predominant organism with compatible Gram stain

0.97 (0.74,1.27)

.81

0.84b (0.64,1.1)

.21

1.11 (0.52,2.36)

.79

0.72b (0.55,0.95)

.02

1.26 (0.51,3.13)

.62

Predominant
organism without
compatible Gram
stain

0.86 (0.61,1.23)

.42

0.51b (0.31,0.83)

<.01

1.24 (0.65,2.37)

.52

0.68 (0.45,1.04)

.07

1.59 (0.6,4.2)

.35

Abbreviations: CI, confidence interval; OR, odds ratio.
High-quality induced sputum defined as <10 epithelial cells per low-power field. Radiographic pneumonia (CXR+) defined as any abnormal chest radiograph (CXR) (consolidation and/or other
infiltrates). Nonpneumonia case defined as a case with a normal CXR, blood culture pathogen negative, and normal respiratory rate or nonhypoxic in the absence of crackles, or normal
respiratory rate and nonhypoxic in the presence of crackles.
a

Other nonfermentative gram-negative rods include Pseudomonas aeruginosa, Acinetobacter species, Pseudomonas species.

b

P < .05.

status. Indeed, for S. pneumoniae and M. catarrhalis, microorganisms that can also be part of the normal oropharyngeal
flora, isolation tended to be associated with nonpneumonia
status, especially in the absence of a compatible Gram stain
smear. In addition, among children with microbiologically
confirmed pneumonia, culture of induced sputum often
detected a different organism than that detected from the
sterile-site culture. While it is certainly possible that some of
these children had polymicrobial pneumonia, this finding further highlights concerns about the nonspecificity of induced
sputum culture in this age group, even when restricted to
high-quality specimens that meet a rigorous definition of culture positivity. It may be possible that induced sputum does
not adequately capture what is in the lung and/or that there is
inevitable contamination with oropharyngeal flora that compromises even high-quality sputum.
It is standard laboratory practice to interpret sputum culture
results in conjunction with the Gram stain smear of the same
specimen [25, 26]. This follows the principle that, in general, an
organism that acts as a pathogen rather than as a colonizer will
be present in sufficient quantity to be seen on direct microscopy
as well as to be detected by culture. Greater significance is given
to organisms that grow in large amounts and are seen in the
Gram stain. Despite a trend for the odds ratios of most organisms associated with CXR+ pneumonia to be higher when there
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was a compatible Gram stain compared to when there was not,
this did not alter the fact that no culture results were associated
with radiographic pneumonia.
This study has several limitations. Most importantly, the
alternative diagnoses in the nonpneumonia cases (all of whom
had respiratory symptoms) were largely unknown and there
is residual uncertainty about the appropriateness of using this
group as a comparator. It is possible that a large proportion
of these cases actually did have pneumonia that was yet to
be detected radiographically and that the lack of association
between sputum culture results and pneumonia may simply
indicate misclassification of “nonpneumonia” episodes. Also,
nonpneumonia cases were not equally represented across sites
[20]. In addition, about three quarters of cases had received
antibiotics before collection of induced sputum, and isolation
of potential pathogens in specimens from these children was
less common than in those who had not received antibiotics.
We may not have had the statistical power to detect associations with case status in those who did not receive antibiotics
given the relatively smaller number in this group. We were also
reliant on an imperfect definition of prior antibiotic use that
may have failed to identify all the cases who had received antibiotics [27]. Another potential limitation is interobserver variability in reporting microscopy and culture results. However,
uniform standard operating procedures, on-site training, and

internal and external quality checks were incorporated into the
PERCH study in an effort to standardize reporting across sites,
and quality reviews indicated that these procedures were being
followed in a consistent manner [24]. Despite these efforts to
standardize methods and to collect all relevant data, there is
still a subjective element to sputum culture interpretation that
may not have been captured by the variables collected and used
in the analyses.
In summary, isolation of bacteria from induced sputum did
not reflect CXR+ pneumonia in young children hospitalized
with WHO-defined severe or very severe radiographic pneumonia. Despite potential confounding by antibiotic use and
the limitations of the study design, these findings did not provide sufficient evidence to incorporate induced sputum culture results into the primary etiology analysis of the PERCH
study. Furthermore, the findings of this study do not support
the culture of induced sputum specimens as a diagnostic tool
for pneumonia in young children as part of routine clinical
practice.
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